MoonLake Total Other Income Expense Net from 2010 to 2025

MLTX Stock  USD 39.86  0.02  0.05%   
MoonLake Immunotherapeuti Total Other Income Expense Net yearly trend continues to be fairly stable with very little volatility. Total Other Income Expense Net is likely to outpace its year average in 2025. During the period from 2010 to 2025, MoonLake Immunotherapeuti Total Other Income Expense Net regression line of annual values had r-squared of  0.45 and arithmetic mean of  3,517,884. View All Fundamentals
 
Total Other Income Expense Net  
First Reported
2010-12-31
Previous Quarter
22.1 M
Current Value
23.2 M
Quarterly Volatility
7.9 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check MoonLake Immunotherapeuti financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MoonLake Immunotherapeuti's main balance sheet or income statement drivers, such as Depreciation And Amortization of 11.3 K, Other Operating Expenses of 34.1 M or Total Operating Expenses of 150.2 B, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.0072. MoonLake financial statements analysis is a perfect complement when working with MoonLake Immunotherapeuti Valuation or Volatility modules.
  
Check out the analysis of MoonLake Immunotherapeuti Correlation against competitors.

Latest MoonLake Immunotherapeuti's Total Other Income Expense Net Growth Pattern

Below is the plot of the Total Other Income Expense Net of MoonLake Immunotherapeutics over the last few years. It is MoonLake Immunotherapeuti's Total Other Income Expense Net historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MoonLake Immunotherapeuti's overall financial position and show how it may be relating to other accounts over time.
Total Other Income Expense Net10 Years Trend
Slightly volatile
   Total Other Income Expense Net   
       Timeline  

MoonLake Total Other Income Expense Net Regression Statistics

Arithmetic Mean3,517,884
Geometric Mean73,321
Coefficient Of Variation224.39
Mean Deviation5,618,615
Median14,922
Standard Deviation7,893,877
Sample Variance62.3T
Range23.2M
R-Value0.67
Mean Square Error37T
R-Squared0.45
Significance0
Slope1,106,509
Total Sum of Squares934.7T

MoonLake Total Other Income Expense Net History

202523.2 M
202422.1 M
202310.1 M
2022591.7 K
202127.7 K

About MoonLake Immunotherapeuti Financial Statements

MoonLake Immunotherapeuti investors use historical fundamental indicators, such as MoonLake Immunotherapeuti's Total Other Income Expense Net, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in MoonLake Immunotherapeuti. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Other Income Expense Net22.1 M23.2 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for MoonLake Stock Analysis

When running MoonLake Immunotherapeuti's price analysis, check to measure MoonLake Immunotherapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MoonLake Immunotherapeuti is operating at the current time. Most of MoonLake Immunotherapeuti's value examination focuses on studying past and present price action to predict the probability of MoonLake Immunotherapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MoonLake Immunotherapeuti's price. Additionally, you may evaluate how the addition of MoonLake Immunotherapeuti to your portfolios can decrease your overall portfolio volatility.